Longitudinal analysis of haplotypes and polymorphisms of the APOA5 and APOC3 genes associated with variation in serum triglyceride levels: the Bogalusa Heart Study

Metabolism: Clinical and Experimental

Volumn 55, Issue 12, 2006, Pages 1574-1581

  Hallman, D Michael ^a   Srinivasan, Sathanur R ^b   Chen, Wei ^b   Boerwinkle, Eric ^a,c   Berenson, Gerald S ^b  

^a UNIVERSITY OF TEXAS   (United States)

^b Tulane Center for Cardiovascular Health   (United States)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A4; APOLIPOPROTEIN A5; APOLIPOPROTEIN C3; TRIACYLGLYCEROL;

ADOLESCENT; ADULT; AFRICAN AMERICAN; ALGORITHM; ARTICLE; CAUCASIAN; CHILD; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC MODEL; GENETIC POLYMORPHISM; GENETIC VARIABILITY; GENOTYPE; GROUPS BY AGE; HAPLOTYPE; HUMAN; MALE; OBSERVATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TRIACYLGLYCEROL BLOOD LEVEL;

ADOLESCENT; ADULT; APOLIPOPROTEIN C-III; APOLIPOPROTEINS A; BODY MASS INDEX; CHILD; CHILD, PRESCHOOL; FEMALE; HAPLOTYPES; HUMANS; LONGITUDINAL STUDIES; MALE; POLYMORPHISM, GENETIC; TRIGLYCERIDES;

EID: 36148936452     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2006.07.018     Document Type: Article

References (39)

1. Pennacchio L.A., Olivier M., Hubacek J.A., et al. An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing. Science 294 (2001) 169-173
2. Talmud P.J., Hawe E., Martin S., et al. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet 11 (2002) 3039-3046
3. Horínek A., Vráblík M., Ceska R., et al. T-1131→C polymorphism with the apolipoprotein AV gene in hypertriglyceridemic individuals. Atherosclerosis 167 (2003) 369-370
4. Martin S., Nicaud V., Humphries S.E., et al. Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges. Biochim Biophys Acta 1637 (2003) 217-225
5. Jang Y., Kim J.Y., Kim O.Y., et al. The -1131 T→C polymorphism in the apolipoprotein A5 gene is associated with postprandial hypertriacylglycerolemia; elevated small, dense LDL concentrations; and oxidative stress in nonobese Korean men. Am J Clin Nutr 80 (2004) 832-840
6. Pennacchio L.A., Olivier M., Hubacek J.A., et al. Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels. Hum Mol Genet 11 (2002) 3031-3038
7. Evans D., Buchwald A., and Beil F.U. The single nucleotide polymorphism -1131T→C in the apolipoprotein A5 (APOA5) gene is associated with elevated triglycerides in patients with hyperlipidemia. J Mol Med 81 (2003) 645-654
8. Lai C.-Q., Demissie S., Cupples L.A., et al. Influence of the APOA5 locus on plasma triglyceride, lipoprotein subclasses, and CVD risk in the Framingham Heart Study. J Lipid Res 45 (2004) 2096-2105
9. Lai C.-Q., Tai E.-S., Tan C.E., et al. The APOA5 locus is a strong determinant of plasma triglyceride concentrations across ethnic groups in Singapore. J Lipid Res 44 (2003) 2365-2373
10. Shachter N.S. Apolipoproteins C-I and C-III as important modulators of lipoprotein metabolism. Curr Opin Lipidol 12 (2001) 297-304
11. Surguchov A.P., Page G.P., Smith L., et al. Polymorphic markers in apolipoprotein C-III gene flanking regions and hypertriglyceridemia. Arterioscler Thromb Vasc Biol 16 (1996) 941-947
12. Groenendijk M., Cantor R.M., de Bruin T.W.A., et al. The apoAI-CIII-AIV gene cluster. Atherosclerosis 157 (2001) 1-11
13. Minihane A.M., Finnegan Y.E., Talmud P., et al. Influence of the APOC3 -2854T→G polymorphism on plasma lipid levels: effect of age and gender. Biochim Biophys Acta 1583 (2002) 311-314
14. Waterworth D.M., Ribalta J., Nicaud V., et al. ApoCIII gene variants modulate postprandial response to both glucose and fat tolerance tests. Circulation 99 (1999) 1872-1877
15. Waterworth D.M., Talmud P.J., Bujac S.R., et al. Contribution of apolipoprotein C-III gene variants to determination of triglyceride levels and interaction with smoking in middle-aged men. Arterioscler Thromb Vasc Biol 20 (2000) 2663-2669
16. Berenson G.S., McMahan C.A., Voors A.W., et al. Cardiovascular risk factors in children. The early natural history of atherosclerosis and essential hypertension (1980), Oxford University Press, New York
17. Lipid Research Clinics Program. Manual of laboratory operations vol. I: lipid and lipoprotein analysis. DHEW publication no. (NIH) 75-628 (1974), National Institutes of Health, Washington (DC)
18. Bucolo G., and David H. Quantitative determination of serum triglycerides by the use of enzymes. Clin Chem 19 (1973) 476-482
19. Allain C.C., Poon L.S., Chan C.S.G., et al. Enzymatic determination of total serum cholesterol. Clin Chem 20 (1974) 470-475
20. Srinivasan S.R., and Berenson G.S. Serum lipoproteins in children and methods for study. In: Lewis L.A., and Opplt J.J. (Eds). CRC handbook on electrophoresis. Lipoprotein methodology and human studies vol 3 (1983), CRC Press, Boca Raton (Fla) 185-204
21. 447-Stop polymorphism of lipoprotein lipase is associated with variation in longitudinal serum high-density lipoprotein-cholesterol profiles: The Bogalusa Heart Study. Metabolism 50 (2001) 894-904
22. Hallman D.M., Srinivasan S.R., Chen W., et al. The β2-adrenergic receptor Arg16-Gly polymorphism and interactions involving β2- and β3-adrenergic receptor polymorphisms are associated with variations in longitudinal serum lipid profiles: The Bogalusa Heart Study. Metabolism 53 (2004) 1184-1191
23. Zaykin D.V., Westfall P.H., Young S.S., et al. Testing association of statistically inferred haplotypes with discrete and continuous traits in samples of unrelated individuals. Hum Hered 53 (2002) 79-91
24. Olivier M., Wang X., Cole R., et al. Haplotype analysis of the apolipoprotein gene cluster on human chromosome 11. Genomics 83 (2004) 912-923
25. Talmud P.J., Palmen J., Putt W., et al. Determination of the functionality of common APOA5 polymorphisms. J Biol Chem 280 (2005) 28215-28220
26. Fullerton S.M., Buchanan A.V., Sonpar V.A., et al. The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster. Hum Genet 115 (2004) 36-56
27. Hallman D.M., Groenemeijer B.E., Jukema J.W., et al. Analysis of lipoprotein lipase haplotypes reveals associations not apparent from analysis of the constituent loci. Ann Hum Genet 63 (1999) 499-510
28. Tanck M.W.T., Klerkx A.H.E.M., Jukema J.W., et al. Estimation of multilocus haplotype effects using weighted penalised log-likelihood: analysis of five sequence variations at the cholesteryl ester transfer protein locus. Ann Hum Genet 67 (2003) 175-184
29. Endo K., Yanagi H., Araki J., et al. Association found between the promoter region polymorphism in the apolipoprotein A-V gene and the serum triglyceride level in Japanese schoolchildren. Hum Genet 111 (2002) 570-572
30. Li G.-P., Wang J.-Y., Yan S.-K., et al. Genetic effect of two polymorphisms in the apolipoprotein A5 gene and apolipoprotein C3 gene on serum lipids and lipoprotein levels in a Chinese population. Clin Genet 65 (2004) 470-476
31. Talmud P.J., Berglund L., Hawe E.M., et al. Age-related effects of genetic variation on lipid levels: The Columbia University BioMarkers Study. Pediatrics 108 (2001) E50
32. deFrança E., Alves J.G.B., and Hutz M.H. APOA1/C3/A4 gene cluster variability and lipid levels in Brazilian children. Braz J Med Biol Res 38 (2005) 535-541
33. Merkel M., Loeffler B., Kluger M., et al. Apolipoprotein AV accelerates plasma hydrolysis of triglyceride-rich lipoproteins by interaction with proteoglycan-bound lipoprotein lipase. J Biol Chem 280 (2005) 21553-21560
34. Olofsson S.-O., and Apo A.-V. The regulation of a regulator of plasma triglycerides. Arterioscler Thromb Vasc Biol 25 (2005) 1097-1099
35. Lookene A., Beckstead J.A., Nilsson S., et al. Apolipoprotein A-V-heparin interactions. Implications for plasma lipoprotein metabolism. J Biol Chem 280 (2005) 25383-25387
36. Marçais C., Verges B., Charrière S., et al. Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment. J Clin Invest 115 (2005) 2862-2869
37. Vu-Dac N., Gervois P., Jakel H., et al. Apolipoprotein A5, a crucial determinant of plasma triglyceride levels, is highly responsive to peroxisome proliferator-activated receptor α activators. J Biol Chem 278 (2003) 17982-17985
38. Prieur X., Coste H., and Rodríguez J.C. The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-α and contains a novel farnesoid X-activated receptor response element. J Biol Chem 278 (2003) 25468-25480
39. Fu J., Gaetani S., Oveisi F., et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-α. Nature 425 (2003) 90-93